ADUS Addus HomeCare Corp
Services-Home Health Care Services · Nasdaq · SEC CIK 1468328 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.5%
TTM net income YoY29.7%
TTM EPS YoY29.0%
Revenue 3-yr CAGR13.4%
Net income 3-yr CAGR24.4%
Margins
Gross margin32.3%
Operating margin10.3%
Net margin7.4%
FCF margin9.6%
EBITDA margin11.4%
Returns
ROE10.0%
ROA7.7%
ROIC (approx.)10.5%
Asset turnover1.05x
Leverage & solvency
Liabilities / assets18.6%
Debt / equity0.02x
Current ratio1.64x
Interest coverage19.72x
Cash quality & payout
Operating cash flow / net income1.37x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.42B | $1.15B | $1.06B | $951.12M | $864.50M |
| Cost of revenue | $960.66M | $779.58M | $718.77M | $651.38M | $594.65M |
| Gross profit | $461.87M | $375.02M | $339.88M | $299.74M | $269.85M |
| SG&A expense | $306.85M | $258.80M | $234.79M | $216.94M | $189.42M |
| Operating income | $138.62M | $102.69M | $90.96M | $68.74M | $65.94M |
| Interest expense | $13.61M | $7.73M | $11.11M | $8.91M | $5.81M |
| Pretax income | $127.44M | $99.35M | $81.33M | $60.17M | $60.40M |
| Income tax | $31.54M | $25.75M | $18.81M | $14.15M | $15.27M |
| Net income | $95.91M | $73.60M | $62.52M | $46.02M | $45.13M |
| EBITDA | $155.03M | $116.22M | $105.08M | $82.80M | $80.43M |
| EPS (basic) | 5.31 | 4.33 | 3.91 | 2.90 | 2.87 |
| EPS (diluted) | 5.22 | 4.23 | 3.83 | 2.84 | 2.81 |
| Weighted avg. shares (diluted) | 18.39M | 17.38M | 16.31M | 16.18M | 16.06M |
| Banking | |||||
| Net interest income | — | — | -$9.63M | -$8.57M | -$5.54M |
| Balance sheet | |||||
| Cash & equivalents | $81.62M | $98.91M | $64.79M | $79.96M | $168.90M |
| Receivables | $151.69M | $122.88M | $115.50M | $125.50M | $136.96M |
| Current assets | $269.49M | $260.38M | $200.00M | $222.81M | $324.34M |
| PP&E, net | $25.00M | $24.70M | $24.01M | $21.18M | $18.48M |
| Goodwill | $996.70M | $970.56M | $663.00M | $582.84M | $504.39M |
| Intangibles | $102.41M | $109.64M | $91.98M | $72.19M | $64.32M |
| Total assets | $1.44B | $1.41B | $1.02B | $937.99M | $947.59M |
| Current liabilities | $149.49M | $155.87M | $145.12M | $131.15M | $117.69M |
| Long-term debt | $120.96M | $218.44M | $124.13M | $131.77M | $220.91M |
| Total debt | $120.96M | $218.44M | $124.13M | $131.77M | $220.91M |
| Total liabilities | $352.00M | $442.14M | $317.73M | $304.45M | $373.24M |
| Shareholders' equity | $1.09B | $970.49M | $706.69M | $633.54M | $574.34M |
| Net debt | $39.34M | $119.53M | $59.34M | $51.81M | $52.02M |
| Shares outstanding | 18.52M | 18.15M | 16.23M | 16.13M | 15.94M |
| Cash flow statement | |||||
| Operating cash flow | $111.51M | $116.43M | $112.25M | $105.11M | $39.49M |
| Capital expenditure | $7.72M | $6.05M | $9.45M | $8.30M | $4.64M |
| Free cash flow | $103.79M | $110.38M | $102.79M | $96.81M | $34.84M |
| Investing cash flow | -$32.50M | -$354.61M | -$119.24M | -$106.59M | -$42.02M |
| Financing cash flow | -$96.30M | $272.30M | -$8.18M | -$87.45M | $26.34M |
| Depreciation & amortization | $16.41M | $13.53M | $14.13M | $14.06M | $14.49M |
| Stock-based compensation | $16.42M | $11.16M | $10.32M | $10.62M | $9.43M |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.